Market capitalization | CHF2.29b |
Enterprise Value | CHF2.80b |
P/E (TTM) P/E ratio | 31.22 |
EV/FCF (TTM) EV/FCF | 18.95 |
EV/Sales (TTM) EV/Sales | 2.49 |
P/S ratio (TTM) P/S ratio | 2.04 |
P/B ratio (TTM) P/B ratio | 6.01 |
Dividend yield | 2.38% |
Last dividend (FY23) | CHF3.20 |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
5 Analysts have issued a Dätwyler forecast:
5 Analysts have issued a Dätwyler forecast:
Jun '24 |
+/-
%
|
||
Revenue | 1,121 1,121 |
7%
7%
|
|
Gross Profit | 245 245 |
3%
3%
|
|
EBITDA | 188 188 |
3%
3%
|
EBIT (Operating Income) EBIT | 106 106 |
9%
9%
|
Net Profit | 73 73 |
8%
8%
|
In millions CHF.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Dätwyler Holding AG engages in the supply of system-critical elastomer components for injectable drug delivery systems. It operates through the Healthcare Solutions and Industrial Solutions segments. The Healthcare Solutions segment offers system-critical components for containers and delivery systems for injectable drugs and diagnostics in the pharmaceutical and medical markets. The Industrial Solutions segment manufactures customized system-critical components for applications in the mobility, food, and beverage, and general industry markets. The company was founded in 1915 and is headquartered in Altdorf, Switzerland.
Head office | Switzerland |
CEO | Volker Cwielong |
Employees | 8,178 |
Founded | 1915 |
Website | www.daetwyler.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.